Claudio Festuccia

About Claudio Festuccia

Claudio Festuccia, With an exceptional h-index of 51 and a recent h-index of 30 (since 2020), a distinguished researcher at Università degli Studi dell'Aquila, specializes in the field of oncologia, ricerca di base.

His recent articles reflect a diverse array of research interests and contributions to the field:

General Direct Anticancer Effects of Deer Growing Antler Extract in Several Tumour Cell Lines, and Immune System-Mediated Effects in Xenograft Glioblastoma

A Pharmacological Investigation of Eph-Ephrin Antagonism in Prostate Cancer: UniPR1331 Efficacy Evidence

Compounds for treating brain cancer

Synergistic activity of ketoconazole and miconazole with prochloraz in inducing oxidative stress, GSH depletion, mitochondrial dysfunction, and apoptosis in mouse sertoli TM4 cells

Method and Compositions for Treating Glioblastoma

Therapies for cancer

Anticancer effects of ABTL0812, a clinical stage drug inducer of autophagy-mediated cancer cell death, in glioblastoma models

ATX-101, a peptide targeting PCNA, has antitumor efficacy alone or in combination with radiotherapy in murine models of human glioblastoma

Claudio Festuccia Information

University

Position

___

Citations(all)

7538

Citations(since 2020)

2776

Cited By

5861

hIndex(all)

51

hIndex(since 2020)

30

i10Index(all)

140

i10Index(since 2020)

82

Email

University Profile Page

Università degli Studi dell'Aquila

Google Scholar

View Google Scholar Profile

Claudio Festuccia Skills & Research Interests

oncologia

ricerca di base

Top articles of Claudio Festuccia

Title

Journal

Author(s)

Publication Date

General Direct Anticancer Effects of Deer Growing Antler Extract in Several Tumour Cell Lines, and Immune System-Mediated Effects in Xenograft Glioblastoma

Pharmaceutics

Alessandra Rossetti

Louis Chonco

Nicolas Alegría

Veronica Zelli

Andrés J García

...

2024/5

A Pharmacological Investigation of Eph-Ephrin Antagonism in Prostate Cancer: UniPR1331 Efficacy Evidence

Pharmaceuticals

Claudio Festuccia

Miriam Corrado

Alessandra Rossetti

Riccardo Castelli

Alessio Lodola

...

2023/10/13

Compounds for treating brain cancer

2023/2/16

Synergistic activity of ketoconazole and miconazole with prochloraz in inducing oxidative stress, GSH depletion, mitochondrial dysfunction, and apoptosis in mouse sertoli TM4 cells

International Journal of Molecular Sciences

Sabrina Petricca

Giuseppe Celenza

Carla Luzi

Benedetta Cinque

Anna Rita Lizzi

...

2022/5/12

Method and Compositions for Treating Glioblastoma

2022/11/17

Therapies for cancer

2022/4/26

Anticancer effects of ABTL0812, a clinical stage drug inducer of autophagy-mediated cancer cell death, in glioblastoma models

Frontiers in Oncology

Andrea Mancini

Alessandro Colapietro

Loredana Cristiano

Alessandra Rossetti

Vincenzo Mattei

...

2022/11/2

ATX-101, a peptide targeting PCNA, has antitumor efficacy alone or in combination with radiotherapy in murine models of human glioblastoma

Cancers

Giovanni Luca Gravina

Alessandro Colapietro

Andrea Mancini

Alessandra Rossetti

Stefano Martellucci

...

2022/1/7

From a general anti-cancer treatment to antioxidant or deer osteoporosis: the consequences of antler as the fastest-growing tissue

Tomás Landete-Castillejos

Alessandra Rossetti

Andres J Garcia

Carlos de Cabo

Claudio Festuccia

...

2022/7/18

The botanical drug PBI-05204, a supercritical CO₂ extract of Nerium oleander, augments the antitumor efficacy of radiotherapy in treatment of human glioblastoma

Cancer Research

Alessandro Colapietro

Peiying Yang

Alessandra Rosetti

Andrea Mancini

Flora Vital

...

2022/6/15

Pharmaceutical composition for treating cancer

2022/5/18

The botanical drug PBI-05204, a supercritical CO2 extract of Nerium oleander, sensitizes alveolar and embryonal rhabdomyosarcoma to radiotherapy in vitro and in vivo

Frontiers in Pharmacology

Sara Vaccaro

Alessandra Rossetti

Antonella Porrazzo

Simona Camero

Matteo Cassandri

...

2022/12/1

The importance of tumor stem cells in glioblastoma resistance to therapy

Vincenzo Mattei

Francesca Santilli

Stefano Martellucci

Simona Delle Monache

Jessica Fabrizi

...

2021/4/8

Multiple Antitumor Molecular Mechanisms Are Activated by a Fully Synthetic and Stabilized Pharmaceutical Product Delivering the Active Compound Sulforaphane (SFX-01) in …

Pharmaceuticals

Alessandro Colapietro

Alessandra Rossetti

Andrea Mancini

Stefano Martellucci

Giuseppe Ocone

...

2021/10/26

MS-275 (entinostat) promotes radio-sensitivity in PAX3-FOXO1 rhabdomyosarcoma cells

International Journal of Molecular Sciences

Matteo Cassandri

Silvia Pomella

Alessandra Rossetti

Francesco Petragnano

Luisa Milazzo

...

2021/10/1

Romidepsin (FK228) fails in counteracting the transformed phenotype of rhabdomyosarcoma cells but efficiently radiosensitizes, in vitro and in vivo, the alveolar phenotype subtype

International Journal of Radiation Biology

Alessandra Rossetti

Francesco Petragnano

Luisa Milazzo

Francesca Vulcano

Giampiero Macioce

...

2021/7/3

Lactobacillus sakei pro-bio65 reduces tnf-α expression and upregulates gsh content and antioxidant enzymatic activities in human conjunctival cells

Translational Vision Science & Technology

Roberto Iorio

Sabrina Petricca

Carla Luzi

Pierangelo Bellio

Loredana Cristiano

...

2021/5/3

Forbindelser til behandling af hjernecancer

2021/12/13

At the Bench: Pre-clinical evidence for multiple functions of CXCR4 in cancer

Gary D Luker

Jinming Yang

Ann Richmond

Stefania Scala

Claudio Festuccia

...

2021/5

Targeting DDX3X helicase activity with BA103 shows promising therapeutic effects in preclinical glioblastoma models

Cancers

Annalaura Brai

Valentina Riva

Letizia Clementi

Lucia Falsitta

Claudio Zamperini

...

2021/11/7

See List of Professors in Claudio Festuccia University(Università degli Studi dell'Aquila)